MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jns.2026.126153

Медицинская библиотека · Journal of the neurological sciences · 2026

Plasma signatures of type 2 inflammation and vascular remodeling in moyamoya disease.

Park Silsu, Mineharu Yohei, Funaki Takeshi, Chihara Hideo, Sasagasako Tomoki, Kamata Takahiko, Nakajima Kota, Miyamoto Susumu, Arakawa Yoshiki

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Moyamoya disease (MMD) is an idiopathic cerebrovascular disorder in which chronic inflammation has been implicated, along with genetic susceptibility, including the RNF213 variants. In this study, we examined the relationship between type 2 inflammation and MMD.

METHODS

Blood samples were collected from three groups: 20 patients with MMD, 20 age- and sex-matched unrelated controls, and eight unaffected relatives with the RNF213 p.R4810K variant. Plasma levels of 15 cytokines were quantified using chemiluminescent multiplex ELISA.

RESULTS

IL-13 tended to be higher in patients than in controls, but this difference did not remain significant after correction for multiple comparisons and did not clearly distinguish patients from unaffected carriers. In contrast, IL-5 was significantly higher in patients than in unaffected carrier relatives after multiple-comparison correction (p = 0.0483), as were IL-1β and IL-12p70 (p = 0.00399 and 0.0347). An exploratory model incorporating IL-1β, IL-5, and IL-12p70 yielded an AUC of 0.912 for distinguishing patients from unaffected carriers (p < 0.001). Plasma platelet-derived growth factor-BB (PDGF-BB) levels were significantly lower in patients than in controls and were also lower in the mutant carriers, regardless of whether they developed MMD.

CONCLUSIONS

These findings suggest that type 2 and pro-inflammatory cytokine profiles are associated with MMD status among RNF213 p.R4810K carriers. The exploratory multivariable model requires validation in larger independent cohorts.

Для цитирования: Park Silsu, Mineharu Yohei, Funaki Takeshi, Chihara Hideo, Sasagasako Tomoki, Kamata Takahiko, Nakajima Kota, Miyamoto Susumu, Arakawa Yoshiki. Plasma signatures of type 2 inflammation and vascular remodeling in moyamoya disease.. Journal of the neurological sciences. 2026. DOI: 10.1016/j.jns.2026.126153.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.